Rogers’ beat was cost-led, but the real mispricing is 2026 margin durability on flat revenue

The right read on this print is that Rogers has changed the earnings algorithm before the revenue cycle has visibly turned. What was priced in was a modest top-line recovery from a depressed Q4 FY2024 base: the Street expected $196.5 million of revenue and $0.60 of EPS, which already assumed some improvement after revenue had troughed at $190.5 million in Q1 FY2025 and then recovered to $202.8 million in Q2 FY2025 and $208.4 million in Q3 FY2025. What actually surprised was not demand magnitude, because actual revenue of $201.5 million was only a +2.5% surprise and down -3.3% sequentially, but the conversion of that revenue into adjusted EPS of $0.89 versus the $0.60 estimate, a +48.3% surprise. That distinction matters for the stock: if investors were waiting for a clean orders-led reacceleration, this was not it; if they were skeptical that the company could hold earnings while revenue sits around $200 million, the print directly challenges that skepticism.

The setup into the quarter was also more complicated than a simple beat. Rogers’ quarterly revenue path had been sliding from $243.8 million in Q1 FY2023 to $204.6 million in Q4 FY2023, then to $192.2 million in Q4 FY2024, before stabilizing in 2025 at $190.5 million, $202.8 million, $208.4 million, and $201.5 million. Gross margin followed a less comforting path: 35.2% in Q3 FY2024 gave way to 32.1% in Q4 FY2024, 29.9% in Q1 FY2025, 31.6% in Q2 FY2025, 31.0% in Q3 FY2025, and 31.5% in Q4 FY2025. The market therefore had reason to discount a revenue beat that did not push gross margin back toward the 34.1% to 35.2% zone seen in Q2 FY2024 and Q3 FY2024. The variant perception is that gross margin is no longer the only operating leverage signal to watch, because management has put enough cost action below gross profit to let earnings recover while factory utilization remains imperfect.

That cost-led interpretation is anchored by management’s own reported-account framing, which should be kept separate from the Street-comparison basis. Ali El-Haj described the company’s basis by saying, “Q4 sales of $202 million approached the high end of the guidance,” while the print used for estimate comparison was actual revenue of $201.5 million versus $196.5 million. The more important sentence was his follow-through: “Adjusted EPS of $0.89 per share and adjusted EBITDA margins of 17.1%, both exceeded the top end of guidance.” The wording matters because it commits the quarter’s upside to both EPS and EBITDA margin, not only tax, interest, or buyback mechanics. It also gives investors a margin reference point that is higher than what the gross margin line alone would imply, since gross margin was 31.5% in Q4 FY2025, only up from 31.0% in Q3 FY2025 and still below 32.1% in Q4 FY2024.

The durability question now moves from Q4 evidence to Q1 guidance, and here the print is more favorable than it first appears. Laura Russell guided Q1 revenue to $193 million to $208 million, gross margin to 30.5% to 32.5%, adjusted EBITDA to $27 million to $35 million, and adjusted EPS to $0.45 to $0.85. That revenue range does not ask investors to underwrite a breakout; it straddles the latest quarterly history around $201.5 million in Q4 FY2025 and the subsequent reported $200.5 million for Q1 FY2026. The midpoint language on EPS is more revealing: Russell said, “The $0.65 midpoint compares to adjusted EPS of $0.27 in Q1 of 2025.” The company is effectively telling investors that year-over-year earnings improvement can occur with revenue growth described elsewhere as 5% and gross margin guided only in the 30.5% to 32.5% band. That is the core of the long case after this event: the EPS bridge is not waiting for gross margin to revisit the 35.1% of Q3 FY2023 or 35.2% of Q3 FY2024.

The reason this can work is that management has put hard numbers around the expense reset and cash discipline. El-Haj said Rogers realized $25 million in cost and operating expenses improvement in 2025, with another $20 million of annualized savings expected to be complete by the end of 2026. He also said the 2025 work included an 8% reduction in full year operating expenses compared to the prior year. Russell gave the near-term evidence: Q4 adjusted EBITDA was $34.4 million compared to $23.3 million in Q4 2024, while adjusted operating expense, excluding stock-based compensation, decreased by $6.3 million over the same period. The conflict investors must underwrite is equally numeric: underutilization costs increased by $1.7 million, primarily tied to the start of production for the ceramic China facility. That means the self-help is not costless, and the factory footprint is still absorbing startup drag. But the balance of the numbers favors the margin reset: a $6.3 million adjusted operating expense decrease and $25 million of 2025 cost and operating expenses improvement outweigh a $1.7 million underutilization headwind in the quarter.

The cash flow evidence is the second reason to treat the EPS beat as higher quality than the headline revenue beat. Rogers ended Q4 with $197 million of cash, up $29.2 million from the end of Q3, and generated $46.9 million of cash provided by operations in the quarter. The company used $14.3 million for share repurchases and $4.7 million for capital expenditures in Q4, and for the full year generated $71 million of free cash flow, repurchased shares totaling $52 million, and ended with $197 million of net cash. This matters because the company’s 2026 capital spending plan is not stepping down from an inflated base to flatter free cash flow artificially: full year 2025 capital expenditures were $30 million, at the low end of guidance, while 2026 guidance is $30 million to $40 million. The thesis does not require starving the business of investment; it requires management to convert roughly $200 million quarterly revenue into EBITDA and cash while spending within that $30 million to $40 million full-year capital envelope.

That same cash and cost story has to be balanced against the call’s delivery, which was constructive in prepared remarks but less clean in Q&A. The tone history shows Q4 FY2025 sentiment at 0.42, up from 0.36 in Q3 FY2025 and 0.33 in Q2 FY2025, while prepared_sentiment rose to 0.55 from 0.44 in Q3 FY2025. Guidance_tone was 0.33, only slightly above 0.32 in Q3 FY2025 and equal to 0.33 in Q2 FY2025, which fits a management team that is confident on cost but not declaring a revenue inflection. The warning sign is that uncertainty rose to 43.7 from 38.9, and qa_evasiveness fell to 13.1 from 19.5 but remained above the 9.3 level from Q4 FY2024. The subsequent Q1 FY2026 call mix sharpened the split: sentiment slipped to 0.40 from 0.42, guidance_tone rose to 0.57 from 0.33, prepared_sentiment rose to 0.71 from 0.55, but qa_sentiment fell to 0.14 from 0.25, uncertainty rose to 60.3 from 43.7, and qa_evasiveness rose to 25.1 from 13.1. The read is not that management sounded promotional; it is that scripted guidance became more affirmative while answers carried more uncertainty, which is exactly what one would expect when cost savings are tangible but revenue timing remains dependent on customer ramps.

That tone split also explains why investors should not overpay for future product-cycle optionality yet. El-Haj said the company expects to share more details later in 2026, with revenue impact “sometimes in '27, maybe even late '26.” The phrase earns attention because it does not commit a 2026 revenue step-up; it leaves late 2026 as an upside case and 2027 as the cleaner planning assumption. Craig Ellis framed the debate around initiatives, referencing “$30 million in initiatives” largely executed and “$13 million” of ceramic-related initiatives in 2026, with benefits to gross margin in the back half of the year. Russell’s response added that a cost base dropped from about $210 million in 2024 to about $193 million, $194 million in 2025, and that about 70% of the $25 million was realized in 2025. The practical implication is that investors should attribute nearer-term upside to cost and mix, not to a new ceramic revenue curve that management has not yet dated with precision.

The supply-chain read-through is unusually limited because the data pack lists no named customers of Rogers and no named suppliers to Rogers, so there is no defensible customer-specific or supplier-specific magnitude to pass through. That absence is itself useful for portfolio construction: this print should not be used to make a named second-order call on a specific upstream supplier or downstream semiconductor customer. The proper cross-company read is within the substrates peer set, where Rogers’ latest reported quarter shows $200.5 million of revenue, 32.2% gross margin, and +5.2% revenue YoY. That margin is above 3445.T at 32.3% by not being above it, because 3445.T is listed at 32.3%, and above AXTI at 29.6%, 6890.T at 25.1%, 5802.T at 22.0%, 5713.T at 20.9%, SUOPY at 6.3%, and 7794.T at -86.1%. The relative growth picture is less favorable: AXTI posted +39.1% revenue YoY, 5713.T +22.5%, 5802.T +14.9%, 3445.T +8.7%, and 6890.T +7.3%, all above Rogers’ +5.2%, while SUOPY at +0.8% and 7794.T at +5.9% frame the lower end. The comparative point is therefore precise: Rogers screens like a margin self-help substrate name, not a top-quartile growth substrate name.

The investment debate after this event should focus on whether a roughly $200 million revenue company can sustain EPS nearer the Q4 adjusted level than the Q1 guidance midpoint without a visible revenue acceleration. Bears can point to Q4 diluted EPS of $0.25 in the quarterly history, Q1 FY2026 diluted EPS of $0.24, gross margin of 31.5% in Q4 FY2025 and 32.2% in Q1 FY2026, and Q1 revenue of $200.5 million that was down -0.5% sequentially. Bulls should counter that the relevant estimate-comparison EPS was $0.89 versus $0.60, Q4 adjusted EBITDA margin was 17.1%, Q4 adjusted EBITDA was $34.4 million versus $23.3 million in Q4 2024, and the balance sheet exited with $197 million of net cash. The numbers conflict because GAAP diluted EPS in the quarterly history captures items that adjusted EPS excludes, while management’s adjusted metrics are the basis on which guidance and the Street surprise are discussed. For a portfolio manager, that means position sizing should respect the accounting gap, but the operating signal still points to a business with more earnings control than revenue momentum.

What to watch next quarter is therefore mechanical. Confirmation requires Q1 revenue inside or above the $193 million to $208 million range, gross margin at least within the 30.5% to 32.5% guide, adjusted EBITDA within the $27 million to $35 million range, and adjusted EPS at or above the $0.65 midpoint of the $0.45 to $0.85 range. The thesis breaks if revenue holds near $200.5 million but adjusted EBITDA falls below $27 million, because that would say the $25 million of 2025 cost and operating expenses improvement is not carrying through; it also breaks if gross margin drops below 30.5%, because that would imply underutilization and ceramic China startup costs are overpowering the savings path. Into the next update after the 2026-02-17 call, the key 2026 markers are another $20 million of annualized savings expected to be complete by the end of 2026, capital expenditures held to the $30 million to $40 million full-year plan, restructuring charges moving from the $5.4 million incurred at the end of 2025 toward the $12 million to $20 million total estimated range, and any management language that shifts revenue impact from 2027 into late 2026. If those numbers hold, the market’s likely mistake will have been treating Rogers as a stalled revenue story rather than a cost-reset earnings story with a still-unpriced option on later-cycle ceramic revenue.